CONTRACTS REGISTRY Sample Clauses

CONTRACTS REGISTRY. Notwithstanding the foregoing, Institution, Sponsor and Quintiles hereby acknowledge that this Amendment shall be published together with the Agreement pursuant to Act No. 340/2015 Sb., on Agreements Register. As and between the Parties, Institution agrees to publish this Amendment together with the Agreement pursuant to the foregoing. Any information which constitutes trade secret of either Party is exempted from such publication. For the purposes of this Amendment and the Agreement, such trade secrets include, but are not limited to, Attachment A to the Agreement – Budget and payment schedule, minimum enrollment goal, expected number of Study subjects enrolled and the expected duration of the Study. Furthermore, personal data of individuals are also exempt from such publication, unless they have been previously published in another public register. The Institution is obliged to publish this Amendment together with the Agreement in accordance with the article herein above. The Institution will inform Quintiles of publishing this Amendment together with the Agreement in the Agreements Register by designating the following email address: as the email address to which a notification of publication in the Agreements register shall be sent. Should the Institution fail to publish this Amendment together with the Agreement within 5 working days from its full execution by all parties, it may be published by the Sponsor or Quintiles. The estimated value of financial payment under this Agreement shall be approximately CZK 125,000.
AutoNDA by SimpleDocs
CONTRACTS REGISTRY. Medical Facility, Sponsor and Contractual research organization hereby acknowledge that this Amendment No. 2 will be published together with the Agreement in the Agreements Register pursuant to Act No. 340/2015 Sb., on Agreements Register. As and between the Parties, Medical Facility agrees to publish the Amendment No. 2 and the Agreement pursuant to the foregoing. Any information which constitutes trade secret of either Party is exempted from such publication. For the purposes of the Agreement and the Amendment No. 2, trade secrets include, but are not limited to, Article XIII. “
CONTRACTS REGISTRY. Notwithstanding the foregoing, Institution, Sponsor and Quintiles hereby acknowledge that this Amendment no. 2 shall be published together with the Agreement and Amendment no. 1 pursuant to Act No. 340/2015 Sb., on Agreements Register. As and between the Parties, Institution agrees to publish this Amendment no. 2, Amendment no. 1 together with the Agreement Všechny ostatní podmínky Smlouvy zůstávají v plné platnosti.
CONTRACTS REGISTRY. Institution, Assignor and Assignee hereby acknowledge that this Amendment shall be published together with the Agreement pursuant to the Act No. 340/2015 Coll., on Agreements Register. Any information which constitutes trade secret of either Party is exempted from such publication. For the purposes of this Amendment and the Agreement, such trade secrets include, but are not limited to, Attachment A to the Agreement – Budget and payment schedule, minimum enrollment goal, expected number of Study subjects enrolled and the expected duration of the Study. Furthermore, personal data of individuals are also exempt from such publication, unless they have been previously published in another public register. The Institution is obliged to publish this Amendment together with the Agreement in accordance with the article herein above. The Institution will inform Assignor of publishing this Amendment together with the Agreement in the Agreements Register by designating the following email address: as the email address to which a notification of publication in the Agreements register shall be sent. Should the Institution fail to publish this Amendment together with the Agreement within 15 working days from its full execution by all Parties, it may be published by the Assignor or Assignee. berou na vědomí, že tento Xxxxxxx nabyde účinnosti a bude uveřejněn v registru smluv v souladu xx xxx. č. 340/2015 Sb., o registru smluv, v platném znění Takovémuto uveřejnění nepodléhají ty údaje, které tvoří obchodní tajemství některé ze smluvních Stran. Pro účely tohoto Dodatku a Smlouvy se obchodním tajemstvím rozumí zejména Příloha A Smlouvy – Rozpočet a platební rozvrh, minimální cílový počet zařazení, očekávaný počet zařazených subjektů a očekávaná délka trvání Studie. Xxxx nebudou takovémuto uveřejnění podléhat osobní údaje fyzických osob, ledaže jsou již uveřejněny v jiném veřejně přístupném registru. Za uveřejnění Dodatku a Smlouvy dle předchozího odstavce odpovídá Poskytovatel. Zkoušející souhlasí se zveřejněním svého jména v souvislosti s tímto Dodatkem č. 1 na portále veřejné správy v souladu se zákonem o registru smluv. Postupitel/Postupník se zavazují k xxxxxx redigované verze Dodatku č. 1 před podpisem tohoto Dodatku. . Není-li Dodatek společně se Xxxxxxxx uveřejněn Poskytovatelem ve lhůtě 15 pracovních dní od jeho podpisu všemi smluvními Stranami, jsou k jejich uveřejnění oprávněni Postupitel či Postupník.
CONTRACTS REGISTRY. Notwithstanding the foregoing, Provider of Health Services, Principal Investigator, Sponsor, Roche and Contractual research organization hereby acknowledge that this Amendment No. 3 shall be published together with the Amendment No. 2, the Amendment No. 1 and the Contract pursuant to Act No. 340/2015 Coll., on Agreements Register. As and between the parties, Provider of Health Services agrees to publish this Amendment No. 3 together with the Amendment No. 2, the Amendment No. 1 and the Contract pursuant to the foregoing. Any information which constitutes trade secret of either party is exempted from such publication. For the purposes of this Amendment No. 3, the Amendment No. 2, the Amendment No. 1 and the Contract, such trade secrets include, but are not limited to, Article XIII. to the Contract – Financial aspects, minimum enrollment goal, expected number of Study subjects enrolled and the expected duration of the Study. Furthermore, personal data of individuals are also exempt from such publication, unless they have been previously published in another public register. The Provider of Health Services is obliged to publish this Amendment No. 3 together with the Amendment No. 2, the Amendment No. 1 and the Contract in accordance with the article herein above. The Provider of Health Services will inform Contractual research organization of publishing this Amendment No. 3 together with the Amendment No. 2, the Amendment No. 1 and the Contract in the Agreements Register by designating the following email address:
CONTRACTS REGISTRY. Institution undertakes to ensure that the Agreement is published in the scope modified with respect to the Trade Secret and other data to be excluded from publishing (in particular personal data) through the register of contracts as the public administration information system pursuant to Section 5(1) of Act No. 340/2015 Coll., on special conditions for effectiveness of certain agreements, publishing of such agreements and on the register of contracts (“Contracts Registry Act”). Institution is obliged to publish the Agreement no later than within 10 days after the execution of the Agreement. Institution shall proceed to publish the Agreement in the register of contracts in the scope modified with respect to the Sponsor’s Trade Secret and other data (in particular, personal data) that are to be excluded from publishing so that the time-limit pursuant to Section 5(2) of the Act on the Register of Contracts is preserved. The Institution shall then submit a certificate from the administrator of the register of contracts to Xxxxxxx unless Xxxxxxx is notified directly by the administrator of the register of contracts. Each Party undertakes: (i) to discuss with the other Party the accuracy of the contents of the Agreement to be published (by way of e-mail correspondence) after the details to be excluded from publishing are made illegible and of the metadata to be published before sending a data message to the administrator of the register of contracts with the electronic image of the text contents of the Agreement; and (ii) to inform the other Party before making any other submission in relation to the register of contracts on its own initiative or upon an invitation by the administrator of the register of contracts. 7. 4. Registry Prior to the initiation of enrollment, Sponsor will have the right to publicly register Protocol summaries and Institution contact details from company sponsored trials of both investigational medicinal products and marketed medicinal products that meet at least one of the following criteria: (i) required to be registered by Sponsor pursuant to and in accordance with applicable laws and regulations; (ii) required by the ICMJE for studies intended to be published in the international peer-reviewed literature (xxxx://xxx.xxxxx.xxx); or (iii) from company sponsored trials of both investigational and marketed medicines and products that are adequately-designed and well-controlled, whether or not required by (i) or (ii) of this section abov...
CONTRACTS REGISTRY. Notwithstanding the foregoing, Provider of health services, Principal Investigator, Sponsor, Roche and Contractual research organization hereby acknowledge that this Amendment No. 4 shall be published together with the Amendment No. 1, 2 and 3 and the Contract pursuant to Act No. 340/2015 Coll., on Agreements Register.. The Provider of health services is obliged to publish this Amendment No.
AutoNDA by SimpleDocs
CONTRACTS REGISTRY. Provider represents and warrants to the Sponsor that Provider is required to disclose this Agreement and any amendments thereto, in accordance with Law on Registration of Contracts, n. 340/2015 Coll (the “Act”). Pursuant to the Act, the Provider will promptly publish the Agreement and any amendments thereo in the registry, but in no event shall such publication occur more than fifteen (15) days from the date of last signature of the parties. The contracting Parties agree that anyconfidential information and proprietary information indicated by the Sponsor will be removed prior to the publishing of the contract. Prior to signing this agreement, the Sponsor shall send the final version of the contract to the Provider in a machine-readable format, with a highlighted text of the Agreement considered by the Provider to be confidential and proprietary redacted. The Provider shall publish only the redacted version of the Agreement provided by Sponsor and no other version.
CONTRACTS REGISTRY. Notwithstanding the foregoing, Medical Facility, Sponsor and Contractual research organization hereby acknowledge that this Amendment No. 2 shall be published together with the Agreement and the Amendment No. 1 pursuant to Act no. 340/2015 Sb., on Agreements Register. As and between the Parties, Medical Facility agrees to publish this Amendment No. 2 together with the Agreement and the Amendment No. 1 pursuant to the foregoing. Any information which constitutes trade secret of either Party is exempted from such publication. For the purposes of this Amendment No. 2 and the Agreement with the Amendment No. 1, such trade secrets include, but are not limited to, Article IIIFinancial aspects, minimum enrollment goal, expected number of Study subjects enrolled, the expected duration of the Study, Protocol and Certificate of Insurance. Furthermore, personal data of individuals are also exempt from such publication, unless they have been previously Všechna ustanovení a podmínky Smlouvy, které nejsou výslovně změněny tímto Dodatkem č. 2, zůstávají plně platné a účinné.

Related to CONTRACTS REGISTRY

  • Contracts, etc To enter into, make and perform all such obligations, contracts, agreements and undertakings of every kind and description, with any Person or Persons, as the Trustees shall in their discretion deem expedient in the conduct of the business of the Trust, for such terms as they shall see fit, whether or not extending beyond the term of office of the Trustees, or beyond the possible expiration of the Trust; to amend, extend, release or cancel any such obligations, contracts, agreements or understandings; and to execute, acknowledge, deliver and record all written instruments which they may deem necessary or expedient in the exercise of their powers;

  • Contracts and Leases Schedule 4.10 sets forth a true and complete list of all Leases and executory Contracts of the Company that are material to the Business, and Sellers have delivered to Buyer true and complete copies of all such Leases and Contracts, each as amended as of the Agreement Date (the “Material Contracts”). Subject to receipt of the Necessary Consents and compliance with Section 6.10 and subject to the entry of the Sale Order, and any ancillary orders of the Bankruptcy Court pertaining to assumption and assignment of Contracts (a) each of the Material Contracts is in full force and effect and constitutes a valid and binding obligation of the Company or Sellers, and, to the Knowledge of Sellers, each other party thereto, and (b) except as a result of the commencement of the Bankruptcy Cases, the Company or Sellers are not in breach or default in any material respect under any of the Material Contracts and, to the Knowledge of Sellers, the other parties to such Contracts are not in breach or default in any material respect thereunder (and in each such case, to the Knowledge of Sellers, no event exists that with the passage of time or the giving of notice would constitute such material breach or default in any material respect, result in a loss of material rights, result in the payment of any damages or penalties or result in the creation of any Liens thereunder or pursuant thereto other than Permitted Liens); except (i) for those defaults that will be cured in accordance with the Sale Order, are not required to be cured pursuant to section 365(b)(1)(A) of the Bankruptcy Code, or waived in accordance with section 365 of the Bankruptcy Code, or (ii) to the extent such breach or default would not reasonably be expected to have a Seller Material Adverse Effect. Except for filings in the Chapter 11 Cases, to Sellers’ Knowledge, none of the Material Contracts have been cancelled or otherwise terminated by the Company or Sellers, and neither the Company nor Sellers have not delivered any written notice to any counterparty to such Material Contract regarding any such cancellation or termination by the Company or Sellers.

  • Contracts with Subcontractors a. Grantee may enter into contracts with subcontractors unless restricted or otherwise prohibited in the Contract. b. Grantees are prohibited from subcontracting with for-profit organizations under this Contract. c. Prior to entering into a subcontract agreement equaling or exceeding $100,000, Grantee will obtain written approval from the System Agency. d. Grantee will obtain written approval from System Agency before modifying any subcontract agreement to cause the agreement to exceed $100,000. e. Grantee will establish written policies and procedures for competitive procurement and monitoring of subcontracts and will develop a subcontracting monitoring plan. f. monitor subcontractors for both financial and programmatic performance and will maintain pertinent records. g. submit quarterly monitoring reports to the System Agency in a format determined by the System Agency. h. ensure that subcontracts are fully aware of the requirements placed upon them by state/federal statutes, rules, and regulations and by the provisions of this Contract. i. ensure all subcontracts, must be in writing and include the following: 1. Name and address of all parties and the subcontractor’s Vendor Identification Number (VIN) or Employee Identification Number (EIN); 2. Detailed description of the services to be provided; 3. Measurable method and rate of payment and total not-to-exceed amount of the contract; 4. Clearly defined and executable termination clause; and 5. Beginning and ending dates that coincide with the dates of the Contract. j. ensure and be responsible for the performance of the subcontractor(s). k. not contract with a subcontractor, at any tier, that is debarred, suspended, or excluded from or ineligible for participation in federal assistance programs or if the subcontractor would be otherwise ineligible to abide by the terms of this Contract.

  • Service Contracts (a) The Trustees may, at any time and from time to time, contract for exclusive or nonexclusive advisory, management and/or administrative services for the Trust or for any Series with any Person; and any such contract may contain such other terms as the Trustees may determine, including without limitation, authority for the Investment Adviser to determine from time to time without prior consultation with the Trustees what investments shall be purchased, held, sold or exchanged and what portion, if any, of the assets of the Trust shall be held uninvested and to make changes in the Trust's investments, and such other responsibilities as may specifically be delegated to such Person. (b) The Trustees may also, at any time and from time to time, contract with any Persons, appointing such Persons exclusive or nonexclusive distributor or Principal Underwriter for the Shares of one or more of the Series or other securities to be issued by the Trust. Every such contract may contain such other terms as the Trustees may determine. (c) The Trustees are also empowered, at any time and from time to time, to contract with any Persons, appointing such Person(s) to serve as custodian(s), transfer agent and/or shareholder servicing agent for the Trust or one or more of its Series. Every such contract shall comply with such terms as may be required by the Trustees. (d) The Trustees are further empowered, at any time and from time to time, to contract with any Persons to provide such other services to the Trust or one or more of the Series, as the Trustees determine to be in the best interests of the Trust and the applicable Series. (e) The fact that: (i) any of the Shareholders, Trustees, or officers of the Trust is a shareholder, director, officer, partner, trustee, employee, Manager, adviser, Principal Underwriter, distributor, or affiliate or agent of or for any Person with which an advisory, management or administration contract, or Principal Underwriter's or distributor's contract, or transfer, shareholder servicing or other type of service contract may be made, or that (ii) any Person with which an advisory, management or administration contract or Principal Underwriter's or distributor's contract, or transfer, shareholder servicing or other type of service contract may be made also has an advisory, management or administration contract, or principal underwriter's or distributor's contract, or transfer, shareholder servicing or other service contract, or has other business or interests with any other Person, shall not affect the validity of any such contract or disqualify any Shareholder, Trustee or officer of the Trust from voting upon or executing the same, or create any liability or accountability to the Trust or its Shareholders, provided approval of each such contract is made pursuant to the applicable requirements of the 1940 Act.

  • Assumed Contracts (a) Other than the Assumed Contracts, no existing contracts with Seller shall be assumed by Purchaser, without specific, individual, written consent by Purchaser. (b) Seller shall provide Purchaser a list of all existing contracts on Schedule 3.9(b). Except for the Assumed Contracts, Seller is not a party to or otherwise bound by the terms of any material contract, agreement or obligation, written or oral, affecting the Business or the Assets. Seller shall separately identify each Assumed Contract (i) pursuant to which any other party is granted “most favored party” rights of any type or scope, or containing any non-solicitation or non-competition covenants or other restrictions relating to the Business or that limits the freedom of Seller to engage or participate, or compete with any other Person, in any line of business, market or geographic area, or to make use of any Transferred Intellectual Property, (ii) that is an IP Agreement, (iii) that imposes on Seller payment obligations (contingent or otherwise) in excess of $5,000 per annum, (iv) that provides for payments to Seller in excess of $5,000 per annum, (v) that constitutes a partnership or joint venture agreement, (vi) that evidences outstanding Indebtedness which constitutes an Asset and (vii) that is a Lease. (c) Assumed Contracts (if any) are valid, binding and in full force and effect and enforceable by Seller prior to Closing and by Purchaser upon and after Closing.. Neither Seller, nor, to Seller’s Knowledge, any other party, is in material breach, violation of, or default under, and to the Knowledge of Seller, no event has occurred which, with the lapse of time or the giving of notice, or both, is reasonably likely to result in a breach or violation by Seller or such other party of, or default under, any Assumed Contract, and there are no existing disputes or claims of default relating thereto, or any facts or conditions Known to Seller which, if continued, will result in a material default or claim of default thereunder. Seller has not received any written or, to the Knowledge of Seller, oral notice of the intention of any party to terminate, cancel, amend or not renew any Assumed Contract. Except as set forth in Section 1.7, no consents are necessary for the effective assignment to and assumption by Purchaser of any of the Assumed Contracts including but not limited to the lease on the Premises. Seller has furnished or made available to Purchaser true and complete copies of all Assumed Contracts and descriptions of all material terms of Assumed Contracts that are not in writing, including any amendments, waivers or other changes thereto.

  • Contracts; No Defaults (a) Part 3.17(a) of the Disclosure Letter contains a complete and accurate list, and Sellers have delivered to Buyer true and complete copies, of: (i) each Contract that involves performance of services or delivery of goods or materials by the Company of an amount or value in excess of $100,000. (ii) each Contract that involves performance of services or delivery of goods or materials to the Company of an amount or value in excess of $10,000: (iii) each current Insurance Policy; (iv) each Contract that was not entered into in the Ordinary Course of Business and that involves expenditures or receipts of the Company in excess of $10,000; (v) each lease, rental or occupancy agreement, license, installment and conditional sale agreement, and other Contract affecting the ownership of, leasing of, title to, use of, or any leasehold or other interest in, any real or personal property (except personal property leases and installment and conditional sales agreements having a value per item of less than $10,000, and having an aggregate value of all items having a value per item of less than $10,000 items not exceeding $50,000.00); (vi) each licensing agreement or other Contract with respect to patents, trademarks, copyrights, or other intellectual property, including agreements between the Company and current or former employees, consultants, or contractors regarding the appropriation or the non-disclosure of any of the Intellectual Property Assets; (vii) each collective bargaining agreement and other Contract to or with any labor union or other employee representative of a group of employees; (viii) each joint venture, partnership, and other Contract (however named) involving a sharing of profits, losses, costs, or liabilities by the Company with any other Person; (ix) each Contract containing covenants that in any way purport to restrict the business activity of the Company or limit the freedom of the Company to engage in any line of business or to compete with any Person; (x) each Contract providing for payments to or by any Person based on sales, purchases, or profits, other than direct payments for goods; (xi) each power of attorney that is currently effective and outstanding; (xii) each Contract entered into other than in the Ordinary Course of Business that contains or provides for an express undertaking by the Company to be responsible for consequential damages; (xiii) each Contract for capital expenditures in excess of $10,000; (xiv) each written warranty, guaranty, and or other similar undertaking with respect to contractual performance extended by the Company other than in the Ordinary Course of Business; and (xv) each amendment, supplement, and modification (whether oral or written) in respect of any of the foregoing, except for change orders which will have no material adverse effect to the Company;. (b) Part 3.17(b) of the Disclosure Letter is a work in progress schedule setting forth the total amount of each contract and certain information as reflected in the captions thereto.

  • Existing Contracts Billing terms and provisions contained in existing contracting entity agreements (existing as of the date this policy is approved by the Board of Supervisors) shall remain in effect for the life of the contract. However, when these existing contracts are renegotiated, they shall contain the billing provisions as set forth in this policy.

  • Material Contracts and Commitments (a) Section 3.16 of the Company Disclosure Schedule contains a true and complete list as of the date of this Agreement of all of the following contracts, agreements and commitments, whether oral or written ("Contracts"), to which the Company or any of its subsidiaries is a party or by which any of them or any of their material Company Assets is bound, as each such contract or commitment may have been amended, modified or supplemented: (i) any agreement (including all master commitments and pool purchase contracts) between the Company or any of its subsidiaries and any Agency or Investor pursuant to which the Company and its subsidiaries sold more than $175 million in principal amount of Mortgage Loans during fiscal year 1999, and all insurance or guaranty contracts (including contracts with any private mortgage insurer or Pool (as defined herein) insurance provider with respect to the Mortgage Loans; (ii) any agreement (or group of related agreements) for the lease of personal property to or from any Person providing for rent in excess of $100,000 during any twelve-month period; (iii) any agreement for the lease of real property providing for the payment of rent in excess of $250,000 during any twelve-month period; (iv) any agreement (or group of related agreements) or indemnity under which the Company or any of its subsidiaries has created, incurred, assumed or guaranteed any debt including without limitation any indebtedness for borrowed money, warehouse lines of credit, or any capitalized lease or purchase money obligation (except for intercompany obligations); (v) any agreement under which the Company or any of its subsidiaries has granted a lien, pledge, security interest or other encumbrance upon any of its material assets; (vi) any agreement under which the Company or any of its subsidiaries has an obligation to indemnify a director, officer or employee; (vii) any agreement for the employment of any individual on a full-time, part-time, consulting or other basis other than oral retainers of professionals terminable at will except for employment agreements of employees with a salary of less than $100,000 who have signed the Company's or any of its subsidiaries' standard form employment agreement (excluding commissioned employees); (viii) any agreement concerning confidentiality or noncompetition given by the Company other than those agreements (A) with employees on the Company's standard form employment, (B) related to Company Stock Options, (C) entered into with any Person in connection with the proposed sale of the Company and (D) that do not materially restrict the manner in which the Company or any of its subsidiaries conduct its business; (ix) any other plan, contract or arrangement, whether formal or informal, which involves direct or indirect compensation (including bonus, stock option, severance, golden parachute, deferred compensation, special retirement, consulting and similar agreements and all agreements and arrangements regarding the Company's net branches) for the benefit of one or more of the current or former directors, officers or employees of the Company (other than Company Employee Plans described in Section 3.12(a)); (x) any guaranty or suretyship, performance bond or contribution agreement; (xi) any marketing, sales representative or dealership agreement with respect to which the fees paid or payable by the Company are or will be in excess of $100,000; any material agreement relating to e-commerce or agreements related to the Company's "net branches"; and (xii) any other material contract or commitment. (b) The Company has heretofore made available to the Parent true and complete copies of all of the Contracts required to be set forth in Section 3.16 of the Company Disclosure Schedule. Each such Contract is a valid and binding agreement of the Company or one of its subsidiaries in accordance with its terms, and is in full force and effect (except as set forth in Section 3.16 of the Company Disclosure Schedule), except where the failure to be valid and binding and in full force and effect would not individually or in the aggregate have a Material Adverse Effect. Neither the Company nor any of its subsidiaries is in default with respect to any such Contract, nor (to the Company's Knowledge) does any condition exist that with notice or lapse of time or both would constitute such a default thereunder or permit any other party thereto to terminate such Contract, except as would not have a Material Adverse Effect. To the Company's Knowledge, no other party to any such Contract is in default in any respect with respect to any such Contract, which would have a Material Adverse Effect. No party has given any written notice (i) of termination or cancellation of any such Contract or (ii) that it intends to assert a breach of any such Contract, whether as a result of the transactions contemplated hereby or otherwise, which would have a Material Adverse Effect. Each Contract identified in Section 3.16 of the Company Disclosure Schedule in response to any item under this Section 3.16 shall be deemed incorporated by reference to all other items in this Section 3.16.

  • Material Contracts and Transactions Other than as expressly contemplated by this Agreement, there are no material contracts, agreements, licenses, permits, arrangements, commitments, instruments, understandings or contracts, whether written or oral, express or implied, contingent, fixed or otherwise, to which Pubco is a party except as disclosed in writing to Priveco or as disclosed in the Pubco SEC Documents.

  • Business Contracts All contracts and other agreements (other than the Real Property Leases and Personal Property Leases and the Accounts Receivable) to which the Seller is a party and which are utilized in the conduct of the Business, including without limitation contracts and other agreements relating to suppliers, sales representatives, distributors, consultants, customers, purchase orders, marketing and purchasing arrangements (the "Business Contracts");

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!